Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Muñoz Montiel (Málaga, Spain), E. Salcedo Lobera (Málaga, Spain), P. Ruiz-Esteban (Málaga, Spain), J. Luque Del Pino (Málaga, Spain), M. Sánchez Chaparro (Málaga, Spain), A. Doménech Del Río (Málaga, Spain). CARDIOVASCULAR RISK (CVR) AND EFFECTS ON THE QUALITY OF LIFE AFTER A PHYSICAL REHABILITATION PROGRAM ON COPD PATIENTS BASED ON THEIR PHENOTYPE: EXACERBATOR (E) OR NON-EXACERBATOR (NE). 1947

Member's Comments

No comment yet.

Related content which might interest you: COMPARISON OF PHYSICAL PERFORMANCE AND SPIROMETRY VALUES ACCORDING TO FALL RISK OF COPD SUBJECTS Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy Year: 2020 FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS  ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP) Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 ARE THERE CLINICALLY RELEVANT BENEFITS IN A STRUCTURED PROGRAM OF PHYSICAL ACTIVITY IN COPD? ACTIVEPOC STUDY. Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe Year: 2020 UTILITY OF INCREMENTAL SHUTTLE WALKING TEST (ISWT) IN PREOPERATORY RISK ASSESSMENT OF LUNG CANCER SURGERY (LCS).A COMPARISON WITH THE CARDIOPULMONARY EXERCISE TEST (CPET) Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019 IMPROVING HOME OXIGEN THERAPY IN PATIENTS WITH INTERSTITIAL LUNG DISEASES (ILDs): APPLICATION OF A PORTABLE NON-INVASIVE VENTILATION (NIV) DEVICE Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 NON-CYSTIC FIBROSIS (CF) BRONCHIECTASIS: A 5-YEAR RETROSPECTIVE STUDY WITH A FOCUS ON PATIENTS WITH PRIMARY IMMUNODEFICIENCIES (PID) Source: International Congress 2018 – Management of bronchiectasis and large airway diseases Year: 2018 THE NEW OPPORTUNITIES OF THE PERSONALISED PULMONARY REHABILITATION PROGRAMS IN MANAGEMENT OF COPD PATIENTS: TARGETS AND GOALS Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases Year: 2019 PAIN AND FRAILTY IN COPD PATIENTS: RELATIONSHIP AND IMPACT ON WELLBEING AND HEALTH STATUS Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018 THE IMPACT OF PULMONARY REHABILITATION ON PHYSICAL ACTIVITY AND PHYSICAL FITNESS LEVELS IN LUNG TRANSPLANT CANDIDATES; PRELIMINARY STUDY RESULTS Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases Year: 2017 DEVELOPMENT OF A DIGITAL TELEREHABILITATION SOLUTION: ANALYSIS OF THE NEEDS OF PATIENTS WITH CHRONIC DISEASES Source: International Congress 2017 – Latest insights into chronic care Year: 2017 HEALTH RELATED QUALITY OF LIFE (HRQoL) AMONG PATIENTS WITH NON CYSTIC FIBROSIS BROCHIECTASIS (BE) IN STABLE PHASE Source: International Congress 2018 – Management of bronchiectasis and large airway diseases Year: 2018 CHARACTERIZATION AND SURVIVAL OF PATIENTS WITH SPINAL MUSCLE ATROPHY TYPE 1 ON HOME MECHANICAL VENTILATION PROGRAM OF MINISTRY OF HEALTH, CHILE Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases Year: 2017 VALIDATION OF AN ASSESSMENT TOOL FOR CONTROL IN COPD: ANALYSIS OF CLINICAL VARIABLES. Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 SLEEP APNOEA AS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR DISEASE: CURRENT EVIDENCE, BASIC MECHANISMS AND RESEARCH PRIORITIES. Source: Eur Respir J 2007; 29: 614 Year: 2007 EVALUATION OF SMALL AIRWAY DISEASE (SAD) IN ASTHMA. CONCORDANCES AND DISCREPANCES BETWEEN DIFFERENT TECHNIQUES. Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN DIFFERENT PHENOTYPES OF COPD Source: International Congress 2017 – Management of asthma in different situations Year: 2017 PULMONARY REHABILITATION EFFECT ON SYSTEMIC INFLAMMATION VALUES, APOB48, LIPIDEMIA AND CARDIOVASCULAR RISK IN PATIENTS WITH COPD Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases Year: 2019 OBSTACLE OF PHYSICAL ACTIVITY AND ACTIVITIES OF DAILY LIVING IN PATIENTS WITH COPD: DYSPNEA RELATED KINESIOPHOBIA Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients Year: 2019 BACTERIAL IMMUNOTHERAPY IN COPD AND/OR BRONCHIECTASIS FREQUENT EXACERBATOR PATIENTS. A RETROSPECTIVE STUDY. Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD Year: 2018 NONCOMPLIANCE & TOBACCO USE IN PATIENTS WITH LONG-TERM OXYGEN THERAPY (LTOT) Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019